Press release
U.S. Pharmacogenomics Market Size Set to Hit USD 5.6 Billion by 2031 with a CAGR of 8.7%: AMR
U.S. Pharmacogenomics Market
The U.S. pharmacogenomics market is experiencing significant growth due to several driving factors. Firstly, advancements in genomic research and technology have enabled personalized medicine approaches, which utilize genetic information to determine the most effective treatments for individuals. This has increased the demand for pharmacogenomics testing and analysis. Secondly, growing awareness among healthcare professionals and patients about the potential benefits of pharmacogenomics in optimizing drug therapy is driving adoption. Additionally, the rising prevalence of chronic diseases and the need for more targeted therapies further fuel the market growth. Moreover, supportive government initiatives, increasing investment in research and development, and collaborations between pharmaceutical companies and research institutions are contributing to the market expansion.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/47832
๐๐จ๐ฉ ๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข Thermo Fisher Scientific Inc.
โข Illumina, Inc.
โข F. Hoffmann-La Roche Ltd.
โข QIAGEN
โข Agilent Technologies, Inc.
โข Eurofins Scientific
โข Bio-Rad Laboratories, Inc.
โข Danaher Corporation
โข Becton, Dickinson and Company
โข Myriad Genetics, Inc.
๐๐ ๐๐ก๐๐ซ๐ฆ๐๐๐จ๐ ๐๐ง๐จ๐ฆ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง: -
The pharmacogenomics market can be segmented based on technology, application, end-user, and region. Here's a brief overview:
By Technology
โข Next Generation Sequencing
โข Polymerase Chain Reaction
โข Gel Electrophoresis
โข Mass Spectrometry
โข Microarray
โข Others
By Application
โข Cardiovascular Diseases
โข Infectious Diseases
โข Oncology
โข Neurological Diseases
โข Psychiatry
โข Others
By End User
โข Hospitals & Clinics
โข Research Institutions
โข Academic Institutes
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/47832
Key Findings Of Study
โข By technology, the polymerase chain reaction segment was the highest contributor to the U.S. Pharmacogenomics Market in 2021.
โข Depending on application, the oncology segment dominated the U.S. Pharmacogenomics Market in 2021, and is expected to continue this trend during the forecast period.
โข Depending on end user, the hospitals & clinic segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release U.S. Pharmacogenomics Market Size Set to Hit USD 5.6 Billion by 2031 with a CAGR of 8.7%: AMR here
News-ID: 3374423 • Views: โฆ
More Releases from Allied Market Research (AMR)
Mobile Battery Market to Reach $38.6 Billion by 2030 with 6.3% CAGR By Top Key P โฆ
The mobile battery market size was valued at $21.2 billion in 2020, and is projected to reach $38.6 billion by 2030, growing at a CAGR of 6.3% from 2021 to 2030. Mobile batteries are the batteries used to provide electric power to mobile phones for their operations.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.alliedmarketresearch.com/request-sample/A15475
Mobile phones or smartphones have become the most integral part of everyday life. Mobile phones are notโฆ
Yeast Flakes Market Surges: Global Revenue Expected to Reach $1.45 Billion by 20 โฆ
According to a new report published by Allied Market Research, titled, "Yeast Flakes Market by Form and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030,"
๐๐๐ญ ๐
๐ฎ๐ฅ๐ฅ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ : https://www.alliedmarketresearch.com/request-sample/16262
๐๐ฑ๐๐ข๐ญ๐ข๐ง๐ ๐๐๐๐๐ซ ๐๐ฅ๐๐ซ๐ญ! ๐ ๐๐๐ญ ๐ ๐๐๐ฌ๐ฌ๐ข๐ฏ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐๐จ๐ฎ๐ซ ๐๐๐ฑ๐ญ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐! ๐๐ฎ๐ฒ ๐ง๐จ๐ฐ ๐๐ง๐ ๐ญ๐๐ค๐ ๐๐๐ฏ๐๐ง๐ญ๐๐ ๐ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ฅ๐ข๐ฆ๐ข๐ญ๐๐-๐ญ๐ข๐ฆ๐ ๐จ๐๐๐๐ซ. ๐๏ธ
The global yeast flakes market size was valued at $610.2 million in 2020, and is projectedโฆ
Food 3D Printing Market Set to Soar, Projected to Reach $15.1 Billion by 2031
According to a new report published by Allied Market Research, titled, "Food 3D Printing Market," The Food 3D Printing Market Size was valued at $226.20 million in 2021, and is estimated to reach $15.1 billion by 2031, growing at a CAGR of 52.8% from 2022 to 2031.
โถ ๐๐๐ญ ๐
๐ฎ๐ฅ๐ฅ ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ : https://www.alliedmarketresearch.com/request-sample/A08587
๐๐ฑ๐๐ข๐ญ๐ข๐ง๐ ๐๐๐๐๐ซ ๐๐ฅ๐๐ซ๐ญ! ๐ ๐๐๐ญ ๐ ๐๐๐ฌ๐ฌ๐ข๐ฏ๐ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐๐จ๐ฎ๐ซ ๐๐๐ฑ๐ญ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐! ๐๐ฎ๐ฒ ๐ง๐จ๐ฐ ๐๐ง๐ ๐ญ๐๐ค๐โฆ
Dental Alloys Market Insights: Key Drivers of Growth and Challenges
The report indicates that the global dental alloys industry, which generated $1.9 billion in 2021, is expected to reach $3.1 billion by 2031, growing at a CAGR of 4.9% from 2022 to 2031.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ: https://www.alliedmarketresearch.com/request-sample/A17437
Prime Determinants of Growth
The market is driven by increasing demand for dental implants, a growing geriatric population, and the use of dental alloys in producing denture bases and partial denture structures. However,โฆ
More Releases for Pharmacogenomics
Pharmacogenomics Market Is Booming Worldwide 2022-2028
Another factual information on the ""Pharmacogenomics Market"" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the overall industry, drivers, restrictions, opportunities. It gives an investigative view to settle on further choices in organizations. It covers comprehensive instructive information of various key players working over the globe.
Get PDF Brochureโฆ
Pharmacogenomics Market || Global Forecast and Analysis 2020-2030
The study of Pharmacogenomics Market published by Prophecy Market Insights offerings all compilation of the historical, current and future outlook of the market. This report is very helpful for understanding the market complexity. This report will help manufacturers, distributors, and retailers to realize and understand the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue etc. Also thisโฆ
Pharmacogenomics Market Size & Share Expanding Across the Globe
Allied Market Research published a report, titled, "Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Opportunity Analysis and Industry Forecast, 2017 โ 2025." The report provides a comprehensive analysis of top investment pockets, drivers & opportunities, majorโฆ
Pharmacogenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Pharmacogenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-paediatric-sports-medicine-market_p104058.html
ย
Pharmacogenomics is the study of the role of theโฆ
Pharmacogenomics Market Analysis, Forecast, and Assessment 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individualโs reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individualโs genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses thatโฆ
Pharmacogenomics Market : Share, Analysis To 2025
Pharmacogenomics is the study of inherited variations in human genes that affect an individualโs reaction to a particular drug. It co-integrates genetic science with pharmaceutical science. Hence, it is the science of individualizing a drug based on an individualโs genetic makeup. Pharmacogenomics is also linked to personalized medicine, as environmental conditions, genetic variations, and changing lifestyle greatly influence the type and severity of diseases as well as therapeutic responses thatโฆ
